Delivery Order SPE2DB22D3011-SPE2DB24FP9SB
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a potential value of $2,194.16 and a completion date of January 26, 2024. This award does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,131.02 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $5,828.89 and a period of performance through April 4, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,049.48 firm fixed price delivery order contract to supply the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceuticals and medical supplies to DLA...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,194.16, has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor and is not operating under a set-aside designation. This delivery order is issued under a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $2,662.44 and a performance period ending on April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a completion date of February 1, 2024 and a potential value of $1,524.22. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a maximum value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,194.16 and a period of performance through April 9, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA with a potential value of...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9SBDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The potential value of this contract is $5,623.10 and the period of performance runs through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This award is under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 3/7/24 |